Healthcare and Life Science
Nuclera extends Series C funding to $87M to advance antibody engineering
Additional $12M financing led by Elevage Medical Technologies and Jonathan Milner alongside existing investors British Business Bank, and GK GohThe funding will accelerate development of eProtein Discovery for full-format antibody expression, purification, and binding validationCambridg...
Why cultural literacy has become an execution skill in life sciences
In life sciences, execution failures are often explained in familiar terms: regulatory complexity, funding constraints, or technological readiness. Yet in practice, many promising initiatives stall or unravel for a quieter reason — misaligned assumptions between people, professions and ...
OutSee completes seed funding round and establishes partnership with o2h discovery for lead drug target candidate
Oversubscribed £2.5M seed round led by Ahren Innovation CapitalStrategic collaboration with o2h to progress drug discovery programmeCambridge, UK, 12 January 2026: OutSee, a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery...
iXCells Biotechnologies appoints Steve Smith as CEO
Appointment strengthens leadership team as iXCells focuses on expanding its portfolio of custom-tailored iPSC products and delivery of enhanced preclinical services ...
Advancing UK MedTech innovation with collaboration - London Institute for Healthcare Engineering partnership with Team Consulting
Team Consulting is delighted to announce a new collaboration with the London Institute for Healthcare Engineering (LIHE), part of King’s College London. Drawing on our 40-year track record in healthcare innovation, this partnership marks an acceleration in the journey from breakthrough ...
FairJourney Bio launches cryo-EM services with advanced laboratories in San Diego, USA
Expanded offering provides high-resolution structural insights to support antibody discovery and biologic designPORTO, Portugal, and SAN DIEGO, USA, 12 January 2026 – FairJourney Bio (FJBio), a leading global provider of antibody discovery and development services, today announced ...
Qureight appoints Rebecca Simmons as Chief Operating Officer
Experienced operational leader across medical research and deep tech appointed to support sustainable growth as part of Qureight’s strategy to scale company operationsCambridge, UK, 12 January 2026 – Qureight, a techbio company advancing the understanding of lung and heart disease throu...
Enhanced Genomics appoints Dr Katerina Leftheris to its Board of Directors
Experienced leader in preclinical and clinical drug development will support expansion of Company’s therapeutics pipeline for complex and common genetic diseases ...
Why 454 million people are waiting for a device already in their pocket
The Smartphone Revolution in Respiratory Care Has Arrived, And It Changes EverythingHere's an uncomfortable truth: we've had the technology to transform respiratory diagnostics for years. It's sitting in your pocket right now. ...
FairJourney Bio to present at J.P. Morgan 2026 Healthcare Conference
PORTO, Portugal, 08 January, 2026 – FairJourney Bio (FJBio), a global leader in antibody discovery and development, announced today that its Chief Executive Officer, Dr. Werner Lanthaler, will present at the J.P. Morgan 2026 Healthcare Conference, taking place from January 12 – 15, 2026...